- Investing Ideas
- Spanish Pharmaceuticals & Biotech Healthy high growth potential
Spanish Pharmaceuticals & Biotech Healthy high growth potential
Results
2
Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.
2 companies
Pharma Mar
Market Cap: €1.4b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€79.30
7D
4.9%
1Y
-4.1%
Oryzon Genomics
Market Cap: €242.4m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.
ORY
€2.96
7D
1.9%
1Y
7.6%